Sign inJoin waitlistJoin the waitlist

Mary Chamberlin

, Director of Global Oncology Education · Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital

Credentials: · · · · ·

History

Global Oncology Education · Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
Present
Global Oncology Education · Dartmouth Cancer Center
Present
Geisel School of Medicine
Present

Medical Oncology
2006–2008
Dartmouth Hitchcock Medical Center
2005–2006
Internal Medicine
Fletcher Allen Health Care
2000–2003
The Robert Larner, M.D. College of Medicine at the University of Vermont
1996–2000

Research

Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline
JCO Global Oncology · 2020 · Last of 16 authors · 137 citations
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare…
Clinical Cancer Research · 2022 · 120 citations
An outbreak of Escherichia coli O157 infection following exposure to a contaminated building
JAMA · 2003 · 91 citations

Jonathan Marotti
8 papers
KL
Kathleen Lyons
7 papers
Peter Kaufman
6 papers
GS
Gary Schwartz
5 papers
GT
Gregory Tsongalis
5 papers
MB
Marie Bakitas
4 papers
AW
Adrienne Workman
3 papers · 3 as a resident
Gabrielle Rocque
3 papers
KT
Karen Thorp
3 papers
Kimberly Keene
3 papers
Laura Tafe
3 papers
RB
Richard Barth
3 papers

Clinical trials

Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
Principal investigator · Recruiting · Phase 2
Dartmouth-Hitchcock Medical Center
2024–2031
Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
Principal investigator · Recruiting · Phase 1
Mary D Chamberlin
2024–2028
Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)
Principal investigator · Active not recruiting · Phase 2
Dartmouth-Hitchcock Medical Center
2021–2029
ER Reactivation Therapy for Breast Cancer
Principal investigator · Completed · Phase 2
Dartmouth-Hitchcock Medical Center
2016–2024